05 August 2022 | NewsRegister now | NCIRS webinar - Emerging vaccine preventable diseases and vaccination for travelRead the full article
Watch the recording of our webinar to find out what you need to know to be prepared for influenza and COVID-19 vaccination in 2022.
This webinar was recorded on Tuesday 05 April 2022, and chaired by Professor Kristine Macartney.
Hear from leading experts in the field on:
Professor Kristine Macartney
Director - NCIRS
Kristine Macartney is a paediatrician and infectious disease specialist. She is a medical graduate of the University of NSW and has over 20 years of experience in vaccinology. She has experience working in the USA at the Children’s Hospital of Philadelphia where she was a founding member of the US Vaccine Education Center. Her Doctorate of Medicine was on rotavirus infection, in particular the mucosal immune response to novel vaccine candidates.
She is interested in all aspects of vaccine preventable disease research, particularly policy development, vaccine safety and prevention of viral diseases. She is the Senior Editor of the Australian Immunisation Handbook. Kristine is a Staff Specialist in Infectious Diseases and Microbiology at The Children’s Hospital at Westmead and has a conjoint academic appointment as Professor in the Discipline of Child and Adolescent Health, University of Sydney.
Professor Kanta Subbarao
Director - WHO Collaborating Centre for Reference and Research on Influenza
Professor Kanta Subbarao is the Director of the WHO Collaborating Centre for Reference and Research on Influenza and Professor, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity.
She is a virologist and a physician with specialty training in paediatrics and paediatric infectious diseases. Prior to her arrival in Melbourne, she was a senior scientist at the US National Institutes of Health and Centers for Disease Control and Prevention. Over the years, Dr. Subbarao’ s research has focused on newly emerging viral diseases of global importance including seasonal and pandemic influenza, SARS, MERS and now, SARS-CoV-2. Her current research efforts are directed at understanding the biology and immune responses to influenza viruses and vaccines and SARS-CoV-2.
Professor Allen Cheng
Director, Infection Prevention and Healthcare Epidemiology - Alfred Health
Professor in Infectious Diseases Epidemiology, Chair - Advisory Committee for Vaccines
Allen Cheng is an infectious diseases physician and Professor of Infectious Diseases Epidemiology and Director of the Infection Prevention and Healthcare Epidemiology unit at Alfred Health.
He is the current Chair of the Advisory Committee for Vaccines and a previous member of the Advisory Committee on Prescription Medicines (advising the Therapeutic Goods Administration on vaccine and drug regulation issues). He is also a member of the Australian Technical Group on Immunisation (ATAGI) and the National Influenza Surveillance Committee.
This session was moderated by Associate Professor Bette Liu (Staff Specialist, immunisation - NCIRS) with contribution from Karen Bellamy (Immunisation Nurse Practitioner - Monash Health, Member - Australian Technical Advisory Group on Immunisation (ATAGI), ATAGI COVID-19 Vaccine Working Group).
NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090
We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
Copyright © 2022 NCIRS. All rights reserved
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.
Stay updated with the latest from NCIRS